• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Anticoagulation for stroke prevention. An update].

作者信息

Koennecke H C

机构信息

Gefässzentrum Berlin, Abteilung für Neurologie, Ev. Krankenhaus Königin Elisabeth Herzberge, Berlin.

出版信息

Nervenarzt. 2007 Oct;78(10):1124-9. doi: 10.1007/s00115-007-2350-9.

DOI:10.1007/s00115-007-2350-9
PMID:17851645
Abstract

Given the projected rising prevalence of atrial fibrillation in the near future, an increasing number of older patients will have to be treated in order to prevent stroke and systemic embolism. This article summarizes recent developments in antithrombotic treatment and risk stratification for patients with atrial fibrillation and intends to abate the still prevailing reluctance towards anticoagulation in elderly patients.

摘要

相似文献

1
[Anticoagulation for stroke prevention. An update].
Nervenarzt. 2007 Oct;78(10):1124-9. doi: 10.1007/s00115-007-2350-9.
2
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.“真实世界”的心房颤动抗栓治疗：EORP-AF 初步调查。
Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.
3
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.非维生素K拮抗剂口服抗凝药时代之前心房颤动患者的抗栓治疗：心房颤动患者长期口服抗栓治疗全球注册研究（GLORIA-AF）第一阶段队列研究
Europace. 2016 Sep;18(9):1308-18. doi: 10.1093/europace/euw073. Epub 2016 Jun 21.
4
[Patient with antithrombotic medication. Which do bleedings or preoperative?].
Laryngorhinootologie. 2006 Jan;85(1):50-60; quiz 61-5. doi: 10.1055/s-2005-870375.
5
[Anticoagulation in vulnerable elderly patients with atrial fibrillation : risks and benefits].[老年脆弱房颤患者的抗凝治疗：风险与获益]
Rev Med Suisse. 2020 Sep 16;16(706):1718-1720.
6
[How should anticoagulants be used in recurrent, ischemic and hemorrhagic brain infarctions?].[复发性缺血性和出血性脑梗死应如何使用抗凝剂？]
Dtsch Med Wochenschr. 2003 Oct 17;128(42):2213-4. doi: 10.1055/s-2003-42976.
7
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.加拿大心血管学会 2010 年心房颤动指南：预防心房颤动和心房扑动中的脑卒中及全身性血栓栓塞
Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.
8
Stroke prevention in atrial fibrillation: current status and near-future directions.心房颤动的卒中预防：现状与近期方向。
Am J Med. 2011 Sep;124(9):793-9. doi: 10.1016/j.amjmed.2011.03.013.
9
[Limitations of anticoagulant therapy].[抗凝治疗的局限性]
Neurologia. 2012 Mar;27 Suppl 1:27-32. doi: 10.1016/S0213-4853(12)70005-1.
10
Antithrombotic treatment of atrial fibrillation: new insights.心房颤动的抗血栓治疗：新的认识。
Thromb Res. 2012 Oct;130 Suppl 1:S59-60. doi: 10.1016/j.thromres.2012.08.277.

本文引用的文献

1
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.华法林与阿司匹林用于老年社区房颤人群预防卒中的比较（伯明翰老年房颤治疗研究，BAFTA）：一项随机对照试验
Lancet. 2007 Aug 11;370(9586):493-503. doi: 10.1016/S0140-6736(07)61233-1.
2
Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.老年房颤患者华法林治疗第一年的大出血情况及耐受性
Circulation. 2007 May 29;115(21):2689-96. doi: 10.1161/CIRCULATIONAHA.106.653048. Epub 2007 May 21.
3
Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study.
1981年至2006年间英国牛津郡脑出血发病率及病因的变化：一项基于人群的研究。
Lancet Neurol. 2007 Jun;6(6):487-93. doi: 10.1016/S1474-4422(07)70107-2.
4
Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study.低分子量肝素与阿司匹林治疗亚洲大动脉闭塞性疾病患者急性缺血性卒中的随机对照研究
Lancet Neurol. 2007 May;6(5):407-13. doi: 10.1016/S1474-4422(07)70079-0.
5
Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.动脉源性脑缺血后中等强度口服抗凝剂与阿司匹林对比研究（ESPRIT）：一项随机对照试验
Lancet Neurol. 2007 Feb;6(2):115-24. doi: 10.1016/S1474-4422(06)70685-8.
6
The risk of recurrent stroke after intracerebral haemorrhage.脑出血后复发性中风的风险。
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):836-40. doi: 10.1136/jnnp.2006.106500. Epub 2007 Jan 12.
7
Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study.心房颤动合并急性缺血性卒中患者的入院前抗栓治疗与卒中严重程度：一项观察性研究。
Lancet Neurol. 2006 Sep;5(9):749-54. doi: 10.1016/S1474-4422(06)70536-1.
8
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.氯吡格雷联合阿司匹林与口服抗凝药用于房颤患者预防血管事件的氯吡格雷与厄贝沙坦试验（ACTIVE W）：一项随机对照试验
Lancet. 2006 Jun 10;367(9526):1903-12. doi: 10.1016/S0140-6736(06)68845-4.
9
Antiplatelet use after intracerebral hemorrhage.脑出血后的抗血小板治疗。
Neurology. 2006 Jan 24;66(2):206-9. doi: 10.1212/01.wnl.0000194267.09060.77.
10
Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications.MRI上的脑微出血：患病率、关联因素及潜在临床意义。
Neurology. 2006 Jan 24;66(2):165-71. doi: 10.1212/01.wnl.0000194266.55694.1e.